In our study a missense mutation, named A89T (p.Ala89Thr, c.265G>A) that cause a mutated Pyrin/Marenostrin protein was identified in exon 1 of MEFV gene (Figure
1). A89T was first described in 2004 by Cazeneuve and his friends
7. But they were shared limited information about clinical datas of the patient. They were said that the patient was from Armenian origin and had FMF-related symptoms. To our knowledge, this was the second report of this mutation in the literature and first report from Turkish origin. Mutations and polymorphisms are very rare on exon 1 in the MEFV gene. The only 3% of the described changes of FMF gene have been detected in exon 1 region of MEFV. Ten sequence variants have been identified in exon 1 of the MEFV gene so far. Of these patients, six had missense, 4 of them had silent mutations. Except one, all patients were symptomatic and it should be noted that no insertion or deletion mutation was reported in exon 1 up to date
14.
Büyütmek İçin Tıklayın |
Figure 1: Family Pedigree of proband and nucleotide sequence of exon 1 of the MEFV gene showing a single base substitution in our patient, A89T (p.Ala89Thr, c.265G>A). |
Our patient didn't have a brother or a sister and clinically diagnosed with FMF two years ago. Our investigation indicated that in addition to the proband, her mother had clinical findings with FMF and we detected the same mutation, too. Proband’s father had no complaints with FMF. According to family history, there are no clinical symptomes of the disease in sisters and brothers of the probands’ parents (Figure 1). But it was reported us by probands’ mother, there was an abdominal pain in the probands grandfather. Because he has passed away, the genetic analaysis of patient was not performed for MEFV gene. Despite there was no clinical symptomes of the disease in probans’ grandmother, we invited the grandmother to apply the clinics. Because the probands’ grandmother did not apply the clinics because of the geographical reason, the mutation analysis of the grandmother was not done for MEFV gene.
The proband had fever, abdominal pain, chest pain, arthritis but no family history of FMF. Also there was an appendectomy story with our patient. The recurrency of the attack was once a month. She didn’t use colchicine regularly. Clinical data of the patients are given in Table 1.
This family has been under clinical follow-up especially for their complaints and will be periodically checked for the parameters such as erythrocyte-sedimentation rate, C-reactive protein, CBC (complete blood count), SAA (systemic amyloid AA protein) that can be associated with inflammation.